Executive Summary
67 corporate events are scheduled for May 7, 2026: 66 financial results and 1 board meeting. Companies on the calendar include Acme Solar Holdings Limited, Aditya Birla Lifestyle Brands Limited, Alldigi Tech Limited, Apollo Pipes Limited, Bajaj Holdings & Investment Limited, Bharat Forge Limited and 59 others.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior India Quarterly Results BSE NSE Announcements digest from May 06, 2026.
Scheduled Events (67)
Companies with corporate events on the calendar for this day.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Standalone And Consolidated Financial Results For The Quarter and Year ended March 31, 2026 and Recommending Dividend, If any, on the Shares of the Company for the Financial Year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
Board Meeting Intimation for Considering and Approving the Standalone and Consolidated Audited Financial Results for Quarter and Financial Year ended 31 March 2026 and recommendation of Dividend, If Any.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026 and recommend final dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the audited financial results for the quarter & year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and ESOP Scheme
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve standalone and consolidated Audited Financial Results for the quarter/year ended March 31, 2026 and also to consider recommendation of final dividend for the Financial Year 2025-26.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
The Company has informed the Exchange that a Board meeting to be held on May 07, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 07, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the Standalone and Consolidated Audited Financial Results for the period ended March 31, 2026, dividend and other business matters
To consider and approve annual audited Standalone and Consolidated financial results for the year ended March 31, 2026 and recommend dividend if any
To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026, and recommend dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026 and Final dividend
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve audited financial results (standalone and consolidated) for the year ended on March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the Quarter and Year ended March 31, 2026 and to declare 3rd Interim dividend
To consider and approve the Audited Financial Results for the quarter and year ended on March 31, 2026 and to consider other business items, if any.
Board Meeting Intimation for Approval of Financial Results for Quarter and Financial Year ended March 31, 2026 and Recommendation of Dividend
To consider and approve the financial results for the period ended March 31, 2026 and to recommend dividend, if any, on the equity shares of the Company.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and final dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve inter-alia audited standalone and consolidated financial results for the quarter and year ended 31 March 2026 and recommending final dividend for the financial year 2025-26
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve 1. the Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026, along with Auditors Report.2.Recommend final dividend, if any, to the shareholders for the financial year ended March 31, 2026.3. Other matters as specified in the attached intimation.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider, approve and take on record the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2026.
To consider and approve the financial results for the period ended March 31, 2026
Board Meeting Intimation for Considering And Approving The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31, 2026.
To consider and approve the audited standalone and consolidated financial results for the quarter four and financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising
TARACHAND : 07-May-2026 : The Company has informed the Exchange that a Board meeting to be held on April 30, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 07, 2026, To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend, if any
Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on Thursday, May 07, 2026 to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026, and to recommend the final dividend, if any, for the financial year 2025-26.
To consider and approve the financial results for the period ended March 31, 2026 and dividend, if any.
Vesuvius India Ltd has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve unaudited financial results of the Company for the the first quarter ended on March 31, 2026 and declaration of interim dividend, if any, for the financial year 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the audited financial results for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Source: company filings and exchange event calendars. Times shown in local market time when published.
Get daily alerts with full AI analysis of all 67 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Quarterly Results BSE NSE Announcements
🇮🇳 More from India
View all →June 01, 2026
India Pre-Market Regulatory Roundup — June 01, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India Pre-Market Regulatory Roundup — May 31, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India MCA Corporate Compliance Enforcement — May 31, 2026
India MCA Corporate Compliance Enforcement
May 31, 2026
India RBI Banking Regulatory Enforcement Actions — May 31, 2026
India RBI Banking Regulatory Enforcement Actions